Dr. Bahija Jallal is president of MedImmune, the global biologics research and development unit of AstraZeneca. She is also executive vice president of AstraZeneca and is a member of its senior executive team reporting to the CEO. Dr. Jallal joined MedImmune in March 2006.
Dr. Jallal is chairman of the board of Viela Bio, serves on the board of Anthem Inc. and is a member of the board of trustees of the Johns Hopkins University and the board of directors of the University of Maryland Health Sciences Research Park Corporation.
Dr. Jallal has authored over 70 peer-reviewed publications and has more than 15 patents. She is a member of the American Association of Cancer Research and the American Association of Science. She is also the president of the Association of Women in Science. Dr. Jallal was named the 2017 Woman of the Year by the Healthcare Businesswomen’s Association.